7 completed, 3 active not recruiting, 3 withdrawn, 2 no longer available. 7 Phase 2, 5 Phase 1, 3 Not applicable, 2 Early Phase 1, 1 Phase 3.
Follow carbon-11 acetate: new trials by email Literature Review of carbon-11 acetate trials Research Report on carbon-11 acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) [11C] acetate - Mitral Valve Regurgitation | Early Phase 1 | Withdrawn | University of Alabama at Birmingham | 2027-06-01 | 2025-01-24 | |
| 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant Fluorine F 18 L-glutamate Derivative 18F-FSPG, Carbon C 11 Acetate, Positron Emission Tomography - Adult Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 110 | 2022-02-15 | 2026-06-02 |
| Feasibility of [11C]Acetate-PET in LAM and TSC [11C]acetate - Lymphangioleiomyomatosis, Tuberous Sclerosis Complex | Phase 1 / Phase 2 | Active not recruiting | Brigham and Women's Hospital | 7 | 2021-08-30 | 2026-01-21 |
| Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7) Diet, cold exposure, 18FDG - Type2 Diabetes | Not applicable | Completed | Université de Sherbrooke | 15 | 2017-05-23 | 2025-01-27 |
| 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation 11C-acetate - Mild Cognitive Impairment | Phase 2 | Terminated | University of Pennsylvania | 11 | 2017-01-01 | 2024-01-11 |
| C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer 11C-Acetate - Prostate Cancer Patients | Early Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 6 | 2016-03-01 | 2022-05-18 |
| Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer carbon-11 acetate, fluorine F 18 sodium fluoride, positron emission tomography - Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | Not applicable | Withdrawn | University of Washington | 2015-12-01 | 2016-08-31 | |
| 11C-acetate for Treatment Response After Radiotherapy for HCC 11C-Acetate - Hepatocellular Carcinoma | Phase 2 | Terminated | Justin Sims | 1 | 2015-09-01 | 2017-11-22 |
| C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression Sodium Acetate C11 PET/CT Imaging - Gliomas | Phase 2 / Phase 3 | Withdrawn | Phoenix Molecular Imaging | 2014-05-01 | 2016-09-28 | |
| 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension 11C-acetate, [18F]Fluoro-2-deoxy-2-D-glucose, Cardiac MRI - Pulmonary Hypertension | Phase 2 | Completed | University of Pennsylvania | 21 | 2013-08-01 | 2019-02-05 |
| ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea. [C11]Acetate and HED PET - Heart Failure, Obstructive Sleep Apnea | Not applicable | Active not recruiting | Ottawa Heart Institute Research Corporation | 60 | 2012-07-01 | 2025-11-20 |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma Sodium Acetate C11 - Prostate Cancer | Phase 2 | Completed | Phoenix Molecular Imaging | 2000 | 2011-04-01 | 2019-03-07 |
| Multi-Tracer PET Assessment of Primary Brain Tumors [18F]fluoro-2-deoxy-D-glucose (FDG), 3'-deoxy-3'-[18F]fluorothymidine (FLT), [15O]-H2O - Brain Tumors, Cancer | Phase 1 | Completed | University of Utah | 11 | 2010-11-12 | 2022-04-27 |
| PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy PET Acetate scan, Carbon-11 labeled Acetate - Castrate Resistant Prostate Cancer, Prostate Cancer | Phase 1 | Completed | Daniel Vaena | 5 | 2010-05-01 | 2018-10-02 |
| Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer (C-11 Acetate) - Prostate Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2008-09-10 | 2017-07-11 |
| Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan [11C]Acetate - Prostate Cancer | No longer available | Wendell Yap, MD | 2018-05-16 | |||
| C11 Sodium Acetate PET/CT Imaging of PCa Carbon-11 Sodium Acetate - Prostate Cancer | No longer available | Jonsson Comprehensive Cancer Center | 2020-07-24 |
Prostatic Neoplasms (6) · Carcinoma, Hepatocellular (2) · Brain Neoplasms (1) · Cholangiocarcinoma (1) · Cognitive Dysfunction (1) · Disease (1) · Glioblastoma (1) · Glioma (1) · Heart Failure (1) · Hypertension, Pulmonary (1) · Lymphangioleiomyomatosis (1) · Mitral Valve Insufficiency (1) · Neoplasms (1) · Recurrence (1) · Sleep Apnea, Central (1)
Phoenix Molecular Imaging (2) · University of Pennsylvania (2) · Abramson Cancer Center at Penn Medicine (1) · Brigham and Women's Hospital (1) · Daniel Vaena (1) · Jonsson Comprehensive Cancer Center (1) · Justin Sims (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Ottawa Heart Institute Research Corporation (1) · University of Alabama at Birmingham (1) · University of Utah (1) · University of Washington (1) · Université de Sherbrooke (1) · Wendell Yap, MD (1)
United States (14) · Canada (2)
Carmen P Priolo, MD PhD (1) · Dan Pryma, MD (1) · Daniel Kadrmas, PhD (1) · Daniel Vaena, MD (1) · Evan Yu (1) · Fabio Almeida, M.D. (1) · Fabio Almeida, MD (1) · Howard Colman, MD,PhD (1) · Ilya Nasrallah, MD (1) · John M Hoffman, MD (1) · Justin B Sims, MD (1) · Peter L Choyke, M.D. (1) · Pradeep Bhambhvani, MD (1) · Randy Jensen, MD,PhD (1)
P30CA015704 (1), U24CA220325 (1)